Mod GRF 1-29 & GHRP-2 Blend (10mg)

$84.00

Mod GRF 1-29 & GHRP-2 Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines Mod GRF 1-29, a 29-residue GHRH analogue, with GHRP-2, a 6-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1092

  • Product: Mod GRF 1-29 & GHRP-2 Blend

  • Listed quantity: 10 mg

  • Components: Mod GRF 1-29 and GHRP-2

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: Mod-GRF-1-29-GHRP-2-10mg Category:
Description

Mod GRF 1-29 & GHRP-2 Blend (10mg) for Laboratory Research

Mod GRF 1-29 & GHRP-2 Blend (10mg) is offered by Biotech Peptides for laboratories investigating growth hormone regulatory signaling, receptor convergence, and neuroendocrine feedback pathways. The blend combines Mod GRF 1-29, a synthetic 29-residue GHRH analogue, with GHRP-2, a synthetic 6-residue ghrelin mimetic. 1092

For laboratories looking to buy Mod GRF 1-29 & GHRP-2 Blend, this listing identifies a 10 mg quantity. Confirm the supplied material’s component ratio, salt state, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

Blend Product Information

Property Listing information
Product name Mod GRF 1-29 & GHRP-2 Blend
Listed quantity 10 mg
Components Mod GRF 1-29 and GHRP-2
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 10 mg designation describes the total quantity stated for this listing. It does not independently establish the amount of each component, net peptide content, or confirm that a particular quantity-assay method has been performed.

Reference Molecular Characteristics

The following characteristics describe the reference structures of the two components. They are not analytical confirmation of an individual commercial blend batch.

Component Reference molecular formula Approximate molecular weight PubChem identifier
Mod GRF 1-29 C₁₅₂H₂₅₂N₄₄O₄₂ 3367.9 g/mol 91976842
GHRP-2 C₄₅H₅₅N₉O₆ 818.0 g/mol 6918245

The molecular formulas and molecular weights are documented in the PubChem CJC-1295 Without DAC reference record and the PubChem Pralmorelin reference record. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1090

Mod GRF 1-29 is also known as CJC-1295 without DAC. It is a 29-amino-acid synthetic GHRH analogue. The sequence is documented in the Mod GRF 1-29 research summary and in the Mod GRF 1-29 research summary. 1095

GHRP-2 is also known as Pralmorelin and KP-102. It is a synthetic 6-residue ghrelin mimetic with growth hormone-releasing activity. The sequence is documented in the GHRP-2 research summary and in the GHRP-2 research summary. 1090

GHRH and GHS-R1a Receptor Research

Mod GRF 1-29 binds selectively to the GHRH receptor, a class B G-protein-coupled receptor expressed predominantly on somatotroph cells in the anterior pituitary. Receptor engagement activates adenylyl cyclase, increasing intracellular cyclic AMP concentrations. 1092

GHRP-2 is a selective growth hormone secretagogue receptor agonist that activates the GHS-R1a receptor. Receptor engagement activates phospholipase C, increasing intracellular calcium concentrations. 1090

A study of GHRH and GHRP-2 treatment in ovine pituitary cells reported that GHRH, GHRP-2, and combined GHRH-GHRP-2 increased the levels of GH mRNA and GH release from 0.5 to 2 hours in a time-dependent manner. The investigators also reported that combined GHRH-GHRP-2 altered GHRH-R, GHS-R, Pit-1, sst-1, sst-2, and GH gene expression. 1092

Read the primary GHRH and GHRP-2 study for the experimental design and limitations.

Growth Hormone Pulsatility Research

A study of GHRH and GHRP-2 synergy reported that marked stimulation of pulsatile GH secretion is achieved via GHRH-GHRP synergy. The investigators also reported that AVF, IGF-I, and IGFBP-3 together explained 60% of the variability in GHRH-GHRP synergy. 1094

A separate study of GHRH and GHRP-2 treatment in ovine pituitary cells reported that GHRH, GHRP-2, and combined GHRH-GHRP-2 increased the levels of GH mRNA and GH release from 0.5 to 2 hours in a time-dependent manner. 1092

These findings apply to specific experimental protocols and do not establish that a commercial blend increases growth hormone in humans. 1092

Research Limitations

Published Mod GRF 1-29 and GHRP-2 research examines receptor signaling, cell-based assays, and animal models. It does not establish that a commercial blend increases growth hormone, improves body composition, supports recovery, or treats any condition. 1092

Published research also does not verify the identity, purity, component ratio, quantity, or biological activity of the commercial blend supplied with this listing.

Documentation and Batch Verification

Before selecting Mod GRF 1-29 & GHRP-2 Blend (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Component ratio and total blend quantity.

  • Salt state and counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent component ratios, sequences, or molecular values.

For inquiries, provide “Mod GRF 1-29 & GHRP-2 Blend (10mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About Mod GRF 1-29 & GHRP-2 Blend (10mg)

What is Mod GRF 1-29 & GHRP-2 Blend?

It is a research blend combining Mod GRF 1-29, a synthetic 29-residue GHRH analogue, with GHRP-2, a synthetic 6-residue ghrelin mimetic. 1092

What does the 10mg designation mean?

It is the total quantity stated for this listing. It does not describe the amount of each component, a concentration, or independently establish net peptide content.

Does this blend increase growth hormone?

Published research examines receptor signaling and growth hormone release in specific cell-based and animal models. It does not establish that a commercial blend increases growth hormone in humans. 1092

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial blend using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

Mod GRF 1-29 & GHRP-2 Blend (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery